Andexxa is a recombinant modified human factor Xa protein that received accelerated approval in 2018 for reversal of anticoagulation with rivaroxaban or apixaban due to life-threatening or ...

Fesilty is supplied as a lyophilized powder for reconstitution in a single-dose vial containing approximately 1g of human fibrinogen.

Bisphosphonates may reduce pain intensity in short term, but may result in little to no difference in immediate and medium term.

HealthDay News — The proportion of newborns not receiving intramuscular vitamin K increased from 2017 to 2024, according to a research letter published online December 8 in the Journal of the American ...

HealthDay News — The US Food and Drug Administration (FDA) approved a new safety warning for Depo-Provera, a widely used birth control shot made by Pfizer, alerting patients to a possible risk for a ...

MPR, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve patient outcomes.